KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Treasury Shares (2016 - 2025)

Amgen has reported Treasury Shares over the past 16 years, most recently at $1.2 million for Q4 2025.

  • For Q4 2025, Treasury Shares fell 65.71% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $1.2 million, down 65.71%, while the annual FY2025 figure was $1.2 million, 65.71% down from the prior year.
  • Treasury Shares for Q4 2025 was $1.2 million at Amgen, down from $3.5 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $26.1 million in Q4 2022 and troughed at $1.2 million in Q4 2025.
  • A 4-year average of $10.4 million and a median of $4.6 million in 2021 define the central range for Treasury Shares.
  • On a YoY basis, Treasury Shares climbed as much as 564.86% in 2022 and fell as far as 67.39% in 2022.
  • Year by year, Treasury Shares stood at $21.7 million in 2021, then increased by 20.28% to $26.1 million in 2022, then crashed by 86.59% to $3.5 million in 2024, then crashed by 65.71% to $1.2 million in 2025.
  • Business Quant data shows Treasury Shares for AMGN at $1.2 million in Q4 2025, $3.5 million in Q4 2024, and $26.1 million in Q4 2022.